Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.
暂无分享,去创建一个
Fabian Lara | Amit N. Patel | Erik J Woods | A. Leal | T. Ichim | N. Riordan | E. Woods | M. Murphy | Neil H Riordan | Thomas E Ichim | Amit N Patel | Michael P Murphy | Doru T Alexandrescu | Fabio Solano | Rosalia De Necochea Campion | Eugenia Paris | Constantin A Dasanu | Annette M Marleau | Alejandro Leal | Fabio Solano | A. Marleau | D. Alexandrescu | C. Dasanu | Fabian Lara | R. Campion | Eugenia Paris | Alejandro Leal
[1] J. Ryan,et al. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. , 2007, Clinical and experimental immunology.
[2] A. Flake,et al. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice. , 2002, Journal of pediatric surgery.
[3] C. Choi,et al. Intraarterially delivered human umbilical cord blood‐derived mesenchymal stem cells in canine cerebral ischemia , 2009, Journal of neuroscience research.
[4] A. Connolly,et al. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy , 2002, Neuromuscular Disorders.
[5] S. Miller,et al. Human bone marrow‐derived mesenchymal stem cells induce Th2‐polarized immune response and promote endogenous repair in animal models of multiple sclerosis , 2009, Glia.
[6] Lingyun Sun,et al. Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans , 2009, Stem cells.
[7] Hanns-Ulrich Marschall,et al. Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease , 2006, Transplantation.
[8] Andrea Bacigalupo,et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[9] Yao‐Hua Song,et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. , 2007, Biochemical and biophysical research communications.
[10] M. Rojas,et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. , 2005, American journal of respiratory cell and molecular biology.
[11] M. Yacoub,et al. Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. , 2006, Tissue engineering.
[12] K. Patel,et al. The origin, molecular regulation and therapeutic potential of myogenic stem cell populations , 2009, Journal of anatomy.
[13] V. Dubowitz,et al. Expression of class I and class II MHC antigens in neuromuscular diseases , 1989, Journal of the Neurological Sciences.
[14] Manuel A. González,et al. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. , 2009, Arthritis and rheumatism.
[15] S. Schulz,et al. Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain , 2008, Journal of Neuroimmunology.
[16] S. Bruder,et al. Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy , 1994 .
[17] N. Perico,et al. Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells1 , 2008, The Journal of Immunology.
[18] M. Grounds,et al. Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis , 2004 .
[19] C. Richards,et al. Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy , 1993, Cell transplantation.
[20] P. Law,et al. Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. , 1992, Cell transplantation.
[21] T. Gotoh,et al. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. , 2008, Human molecular genetics.
[22] F. Lanza,et al. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs , 2009, Cytometry. Part B, Clinical cytometry.
[23] Jae Kwon Lee,et al. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. , 2008, Cellular immunology.
[24] M. Grounds,et al. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment , 2008, Neuromuscular Disorders.
[25] L. Pénicaud,et al. Immunomodulatory effect of human adipose tissue‐derived adult stem cells: comparison with bone marrow mesenchymal stem cells , 2005, British journal of haematology.
[26] E. McNally,et al. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. , 2004, Circulation research.
[27] M. Mathru. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung , 2010 .
[28] E. Porreca,et al. Haemostatic Abnormalities, Cardiac Involvement and Serum Tumor Necrosis Factor Levels in X-linked Dystrophic Patients , 1999, Thrombosis and Haemostasis.
[29] Q. Han,et al. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. , 2007, Stem cells and development.
[30] D. García-Olmo,et al. Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal Fistula: a Phase II Clinical Trial , 2009, Diseases of the colon and rectum.
[31] N. Rouas-Freiss,et al. Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells , 2008, Stem cells.
[32] M. Kyba,et al. Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery. , 2009, Experimental cell research.
[33] L. Fouillard,et al. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. , 2008, Cellular immunology.
[34] J. Mendell,et al. Mononuclear cell analysis of muscle biopsies in prednisone‐treated and untreated Duchenne muscular dystrophy , 1991, Neurology.
[35] P. de Coppi,et al. Macrophage-secreted factors enhance the in vitro expansion of DMD muscle precursor cells while preserving their myogenic potential , 2010, Neurological research.
[36] T. Partridge,et al. T-Cell-Dependent Fibrosis in the mdx Dystrophic Mouse , 2000, Laboratory Investigation.
[37] S. Kyo,et al. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. , 2007, Molecular biology of the cell.
[38] P. Pisa,et al. Tumor-Specific Bacteriophages Induce Tumor Destruction through Activation of Tumor-Associated Macrophages1 , 2009, The Journal of Immunology.
[39] Wei Zhang,et al. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. , 2007, Stem cells and development.
[40] J. Gimble,et al. Multipotential human adipose‐derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo , 2008, Journal of cellular physiology.
[41] Colin Chandler,et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation , 2002, Neuromuscular Disorders.
[42] A. Demoule,et al. Expression and regulation of CC class chemokines in the dystrophic (mdx) diaphragm. , 2005, American journal of respiratory cell and molecular biology.
[43] M. Grounds,et al. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice , 2006, Neurobiology of Disease.
[44] E. Schwarz,et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. , 2009, Arthritis and rheumatism.
[45] A. László,et al. Antinuclear factor, smooth and striated muscle antibodies in Duchenne-type muscular dystrophy. , 1983, Acta paediatrica Hungarica.
[46] L. Morandi,et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study , 2003, Journal of Neuroimmunology.
[47] R. Handgretinger,et al. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. , 2008, Blood cells, molecules & diseases.
[48] M. Selig,et al. Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes1 , 2009, The Journal of Immunology.
[49] J-L Li,et al. Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice. , 2008, Cytotherapy.
[50] M. Gunetti,et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial , 2010, Experimental Neurology.
[51] E. Geissler,et al. Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function. , 2009, Transplantation proceedings.
[52] A. Pestronk,et al. Long‐term benefit from prednisone therapy in Duchenne muscular dystrophy , 1991, Neurology.
[53] E. Hoffman,et al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. , 2009, The Journal of clinical investigation.
[54] Alberto Mantovani,et al. Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.
[55] Wen-lin Li,et al. Clonal mesenchymal stem cells derived from human bone marrow can differentiate into hepatocyte‐like cells in injured livers of SCID mice , 2009, Journal of cellular biochemistry.
[56] M. Weller,et al. Toll‐Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow‐Derived Mesenchymal Stem Cells by Inducing Indoleamine‐2,3‐dioxygenase‐1 via Interferon‐β and Protein Kinase R , 2009, Stem cells.
[57] M. Soleimani,et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial , 2009, European journal of gastroenterology & hepatology.
[58] G. Remuzzi,et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. , 2007, Journal of the American Society of Nephrology : JASN.
[59] J. Tidball,et al. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. , 1997, The Journal of clinical investigation.
[60] P. Allavena,et al. Macrophage polarization in tumour progression. , 2008, Seminars in cancer biology.
[61] M. Peschanski,et al. Targeting widespread sites of damage in dystrophic muscle: engrafted macrophages as potential shuttles. , 1996, Gene Therapy.
[62] J. Ryan,et al. Interferon‐γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells , 2007 .
[63] J. D. Porter,et al. Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle , 2003, Neuromuscular Disorders.
[64] Krisztián Németh,et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.
[65] T. Ichim,et al. Cord blood in regenerative medicine: do we need immune suppression? , 2007, Journal of Translational Medicine.
[66] D. Bueno,et al. Journal of Translational Medicine Human Fallopian Tube: a New Source of Multipotent Adult Mesenchymal Stem Cells Discarded in Surgical Procedures , 2022 .
[67] George Karpati,et al. Myoblast transfer in duchenne muscular dystrophy , 1993, Annals of neurology.
[68] J. Schweizer,et al. Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia , 2008, Leukemia.
[69] K. Haginoya,et al. Intramuscular renin–angiotensin system is activated in human muscular dystrophy , 2009, Journal of the Neurological Sciences.
[70] Qiu-ping Xie,et al. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. , 2009, Differentiation; research in biological diversity.
[71] Hao Wang,et al. Endometrial regenerative cells: A novel stem cell population , 2007, Journal of Translational Medicine.
[72] G. D’Antona,et al. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse , 2007, The Journal of pathology.
[73] V. Andersen. Cellular Immunology , 2003, Nordisk medicin.
[74] Lingyun Sun,et al. Transplantation of Human Bone Marrow Mesenchymal Stem Cell Ameliorates the Autoimmune Pathogenesis in MRL/lpr Mice , 2008, Cellular and Molecular Immunology.
[75] L. Gosselin,et al. Targeting the immune system to improve ventilatory function in muscular dystrophy. , 2004, Medicine and science in sports and exercise.
[76] G. Ma,et al. Identification and differentiation of magnetically labeled mesenchymal stem cells in vivo in swines with myocardial infarction. , 2009, International journal of cardiology.
[77] N. Bishopric. Mesenchymal stem cell-derived IL-10 and recovery from infarction: a third pitch for the chord. , 2008, Circulation research.
[78] M. Penn. Importance of the SDF-1:CXCR4 axis in myocardial repair. , 2009, Circulation research.
[79] S. Dima,et al. In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors. , 2009, Translational research : the journal of laboratory and clinical medicine.
[80] Junbiao Chang,et al. Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. , 2008, Reproductive biomedicine online.
[81] Huiling Cao,et al. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. , 2008, International journal of molecular medicine.
[82] Moustapha Hassan,et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.
[83] 北折 俊之. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model , 2009 .
[84] D. Valerio,et al. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. , 2006, Human molecular genetics.
[85] E. Gócza,et al. Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes , 2008, Stem cells.
[86] D. McGrouther,et al. Mobilization of endothelial progenitor cells into the circulation in burned patients , 2007, The British journal of surgery.
[87] P. Law,et al. Cell Transplantation as an Experimental Treatment for Duchenne Muscular Dystrophy , 1993, Cell transplantation.
[88] Ido D. Weiss,et al. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. , 2006, The Journal of investigative dermatology.
[89] J. Bouchard,et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[90] C. Gargioli,et al. PlGF–MMP-9–expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle , 2008, Nature Medicine.
[91] G. Cossu,et al. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? , 2000, The Journal of clinical investigation.
[92] J. Sanchez-Ramos,et al. Stem Cells from Umbilical Cord Blood , 2006, Seminars in reproductive medicine.
[93] J. Chan,et al. Widespread Distribution and Muscle Differentiation of Human Fetal Mesenchymal Stem Cells After Intrauterine Transplantation in Dystrophic mdx Mouse , 2007, Stem cells.
[94] K. L. Gardner,et al. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. , 2007, The Journal of clinical investigation.
[95] F. Lanza,et al. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. , 2008, Cytotherapy.
[96] J. Cerón,et al. Muscle genome-wide expression profiling during disease evolution in mdx mice. , 2009, Physiological genomics.
[97] Min Young Kim,et al. Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis. , 2010, Biochimica et biophysica acta.
[98] P. Law,et al. Feasibility, Safety, and Efficacy of Myoblast Transfer Therapy on Duchenne Muscular Dystrophy Boys , 1992, Cell transplantation.
[99] Techung Lee,et al. Muscular Dystrophy Therapy by Nonautologous Mesenchymal Stem Cells: Muscle Regeneration Without Immunosuppression and Inflammation , 2009, Transplantation.
[100] Eric P. Hoffman,et al. Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology , 2000 .
[101] Brian Tiong Gee Tan,et al. Bone marrow‐derived cells that home to acoustic deafened cochlea preserved their hematopoietic identity , 2008, The Journal of comparative neurology.
[102] Johan T den Dunnen,et al. Local dystrophin restoration with antisense oligonucleotide PRO051. , 2007, The New England journal of medicine.
[103] D. Larner,et al. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation , 2009, Disease Models & Mechanisms.
[104] M. Zatz,et al. Stem cells from umbilical cord blood differentiate into myotubes and express dystrophin in vitro only after exposure to in vivo muscle environment , 2007, Biology of the cell.
[105] Amit N. Patel,et al. Multipotent Menstrual Blood Stromal Stem Cells: Isolation, Characterization, and Differentiation , 2008, Cell transplantation.
[106] Zhaohui Zheng,et al. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. , 2008, Rheumatology.
[107] L. Moretta,et al. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.
[108] G. Dini,et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.
[109] Y. Wang,et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. , 2007, Kidney international.
[110] L. Muul,et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[111] D. Schuppan,et al. Increased mRNA expression of tissue inhibitors of metalloproteinase-1 and -2 in Duchenne muscular dystrophy , 2005, Acta Neuropathologica.
[112] J. Bouchard,et al. First test of a “high-density injection” protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up , 2007, Neuromuscular Disorders.
[113] Amit N. Patel,et al. Allogeneic endometrial regenerative cells: An "Off the shelf solution" for critical limb ischemia? , 2008, Journal of Translational Medicine.
[114] Ioannis Ispirlidis,et al. Time-course of Changes in Inflammatory and Performance Responses Following a Soccer Game , 2008, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[115] B. Nico,et al. Role of tumour necrosis factor α, but not of cyclo‐oxygenase‐2‐derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach , 2007, Neuropathology and applied neurobiology.
[116] H. Blau,et al. Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study , 1997, Muscle & nerve.
[117] M. Nowycky,et al. Brain‐derived neurotrophic factor facilitates maturation of mesenchymal stem cell‐derived dopamine progenitors to functional neurons , 2009, Journal of neurochemistry.
[118] C. Wan,et al. Concise Review: Multipotent Mesenchymal Stromal Cells in Blood , 2007, Stem cells.
[119] J. Miller,et al. Seeking muscle stem cells. , 1999, Current topics in developmental biology.
[120] Francesco Muntoni,et al. Dystrophin and mutations: one gene, several proteins, multiple phenotypes , 2003, The Lancet Neurology.
[121] J. Tidball,et al. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. , 2001, Clinical immunology.
[122] A. Manzur,et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. , 2004, The Cochrane database of systematic reviews.
[123] K. Atkinson,et al. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells. , 2007, Placenta.
[124] T. Okano,et al. Novel Cardiac Precursor‐Like Cells from Human Menstrual Blood‐Derived Mesenchymal Cells , 2008, Stem cells.
[125] J. Bassaganya-Riera,et al. Dysregulated Intracellular Signaling and Inflammatory Gene Expression During Initial Disease Onset in Duchenne Muscular Dystrophy , 2009, American journal of physical medicine & rehabilitation.
[126] W. Weimar,et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. , 2007, Stem cells and development.
[127] M. Grounds,et al. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx mice , 2006, Neuromuscular Disorders.
[128] R. Grange,et al. Telomere shortening in diaphragm and tibialis anterior muscles of aged mdx mice , 2007, Muscle & nerve.
[129] N. Romero,et al. Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy. , 2004, Human gene therapy.
[130] J. Bischofberger,et al. Limited Ca2+ and PKA-pathway dependent neurogenic differentiation of human adult mesenchymal stem cells as compared to fetal neuronal stem cells. , 2010, Experimental cell research.
[131] S. Gerson,et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) , 2002, Bone Marrow Transplantation.
[132] Ice,et al. MYOBLAST TRANSFER IN THE TREATMENT OF DUCHENNE ’ S MUSCULAR DYSTROPHY , 2000 .
[133] A. Eljaafari,et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells , 2009, Diabetologia.
[134] Shing-Hwa Liu,et al. Islet-Like Clusters Derived from Mesenchymal Stem Cells in Wharton's Jelly of the Human Umbilical Cord for Transplantation to Control Type 1 Diabetes , 2008, PloS one.
[135] D. Prockop. Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.
[136] Yun-Hoon Choung,et al. Isolation and characterization of postnatal stem cells from human dental tissues. , 2007, Tissue engineering.
[137] T. Shavlakadze,et al. Proceedings of the Australian Physiological Society Symposium: Myopathies and Muscle Regeneration IMPLICATIONS OF CROSS-TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN-LIKE GROWTH FACTOR-1 SIGNALLING IN SKELETAL MUSCLE , 2008 .
[138] Jong Chun Park,et al. TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. , 2009, Frontiers in bioscience.
[139] Philippe M. Campeau,et al. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner1 , 2009, The Journal of Immunology.
[140] P. Ljungman,et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells , 2007, Leukemia.
[141] J. Pollard. Trophic macrophages in development and disease , 2009, Nature Reviews Immunology.
[142] Amit N. Patel,et al. Feasibility investigation of allogeneic endometrial regenerative cells , 2009, Journal of Translational Medicine.
[143] Y. Li,et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study , 2008, Leukemia.
[144] M. Grounds,et al. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[145] P. Law,et al. Myoblast Transfer Therapy for Duchenne Muscular Dystrophy , 1991, Acta paediatrica Japonica : Overseas edition.
[146] J. Bouchard,et al. Dystrophin Expression in Muscles of Duchenne Muscular Dystrophy Patients After High-Density Injections of Normal Myogenic Cells , 2006, Journal of neuropathology and experimental neurology.
[147] Franco Locatelli,et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. , 2007, Blood.
[148] N. Bresolin,et al. Autologous Transplantation of Muscle-Derived CD133+ Stem Cells in Duchenne Muscle Patients , 2007, Cell transplantation.
[149] A. Engel,et al. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies , 1998, Neurology.
[150] N. Bresolin,et al. VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation. , 2006, Blood.
[151] B. Nico,et al. A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice. , 2005, The American journal of pathology.
[152] A. Sbarbati,et al. Adipose‐Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune Encephalomyelitis , 2009, Stem cells.
[153] J. Galipeau,et al. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[154] D. Weightman,et al. A comparison of the structure of small blood vessels in normal, denervated and dystrophic human muscle , 1975, Journal of the Neurological Sciences.
[155] A. Friedenstein,et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. , 1968, Transplantation.